Frontiers in Pharmacology 5
The use of two different mouse models and adherence to the published preclinical guidelines for ALS 11 gives more confidence in the lack of effect for liraglutide
, (PPI) STRING (v12.0) , GLP-1R GCG, GIP, GLP2R, GNAS, GNB1, VIP, ADCYAP1, PDE3B, POMC, NPPA, DPP4 , , , --
Transition planning between vial sizes Most researchers use 10mg vials for phases 1-2 (1-2mg weekly, consuming about 4-8mg per 4-week block), then switch to 20mg or 30mg vials for phases 3-5 when weekly consumption increases significantly
Pregnancy depletes vitamin D stores, and most postpartum women are deficient
Patients with significant diabetic retinopathy were excluded from tirzepatide trials